Why Is Teladoc (TDOC) Down 9.9% Since Last Earnings Report?

Core Insights - Teladoc's shares have decreased by approximately 9.9% since the last earnings report, underperforming the S&P 500 [1] - Recent estimates for Teladoc have trended upward, with a consensus estimate shift of 6.15% [2] - Teladoc holds a VGM Score of A overall, with a Growth Score of B, a Momentum Score of D, and a Value Score of A [3] - The stock has a Zacks Rank of 3 (Hold), indicating an expectation of in-line returns in the coming months [4] Industry Performance - Teladoc is part of the Zacks Medical Services industry, where CVS Health has seen a 4.8% increase in the past month [5] - CVS Health reported revenues of $97.71 billion for the last quarter, reflecting a year-over-year growth of 4.2% [5] - CVS Health's expected earnings for the current quarter are $1.62 per share, indicating a year-over-year increase of 23.7% [6]